Genital urinary syndrome in postmenopausal women. Menopausal and other perimenopausal disorders
Conditions
Interventions
Intervention 1: Intervention group: This group will be treated with a combination vaginal cream containing Vitamin D 1000 IU / dose and Vitamin E 100 IU / dose once a day for 2 weeks and followed by
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to No maximum
Inclusion criteria
Inclusion criteria: postmenopausal women Has urinary-genital symptoms: vaginal itching, burning, dryness, dyspareunia, urination frequency and burning
Exclusion criteria
Exclusion criteria: Definitely or suspected of having endometrial or breast cancer Women with abnormal vaginal bleeding or vaginal infection Women with Diabetes, CKD, Arthritis, Cardiovascular Disease and Active Hepatobiliary Disease Sensitivity to vitamin E, D or vaginal estrogen Women have spouses with sexual dysfunction Women who have been on hormone therapy for the past 12 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in urinary-genital symptoms. Timepoint: Week 4, 12 and 16 after treatment onset. Method of measurement: Get a history and clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Marital Quality of life. Timepoint: 16 weeks after treatment onset. Method of measurement: Women's Sexual Performance Index Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Moradi
Hamedan University of Medical Sciences
Outcome results
None listed